Chemcrux Enterprises has executed Joint Venture (JV) agreement with Kalintis Healthcare. For the said purpose the company has acquired 50% stake in Joint Venture Company namely ‘Kalichem’. Kalichem has been incorporated with initial Paid-up Share Capital of Rs 1 lakh consisting of 10,000 equity shares of Rs 10 each.
Through Joint Venture, the company is aiming to set up manufacturing base and marketing of Active Pharmaceutical Ingredients (API) and Chemicals and its ingredients for distribution and sales in India initially and subject to mutual agreement of the parties, later for worldwide markets.
Chemcrux Enterprises is engaged in high pressure Oxidation, Chlorosulfonation, Nitration and Aceylation for manufacturing of intermediates for bulk drugs, dyes and pigments.
